In Stock
PT-141 10mg
PT-141 (Bremelanotide) cyclic melanocortin peptide for MC3R and MC4R signaling research. 10mg lyophilized for laboratory and preclinical study.
$79.00
$59.00/ item
š¬ Volume Savings
3 VialsSave 10%
5 VialsSave 15%
10 VialsSave 20% ā Best Value
Quantity
1
Total Price
$59.00š 2 Day Express ā $15 | Add $199.00 for FREE Shipping
For laboratory and research purposes only. Not for human or animal consumption. No medical claims are made.
Compound Information
PT-141 (Bremelanotide) is a synthetic cyclic peptide analogue of alpha-melanocyte-stimulating hormone (Ī±-MSH). It was developed from the MT-2 scaffold and has been studied in both preclinical and clinical settings for its selective activity on melanocortin receptors.
PT-141 acts primarily on melanocortin 3 and 4 receptors (MC3R and MC4R), which are implicated in central melanocortin signaling. Unlike PDE5 inhibitors, its mechanism operates through melanocortin signaling rather than vascular pathways. Clinical research has investigated PT-141 in Phase II and Phase III trials, and a formulation has received FDA approval for a specific indication, providing a body of published clinical data.
Vial Size: 10mg
Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH | Purity: See published COA where available | Storage: Lyophilized powder; store at -20Ā°C.
